Uncover key drivers, emerging technologies, and competitive movements shaping the interventional oncology devices market from 2025–2034 with trusted insights from The Business Research Company
What Are The Future Growth Projections For The Interventional Oncology Devices Market Size?
The interventional oncology devices market has experienced consistent growth in recent years. This market is expected to expand from $2.39 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. Historically, the expansion can be attributed to factors such as an aging population, a rise in cancer cases, increased spending on pharmaceutical research and development, higher healthcare expenditure, and an increasing number of healthcare facilities.
The interventional oncology devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $3.28 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.0%. During the forecast period, this growth is primarily driven by factors such as an aging demographic, a rising inclination towards minimally invasive surgeries (MIS), greater investment in research and development, an uptick in healthcare spending, significant opportunities in developing economies, and the growing incidence of cancer and other chronic conditions. Key trends expected in this timeframe involve a strong emphasis on creating advanced image-guided oncology devices, leveraging AI for innovative device creation, introducing novel and effective embolic devices to enhance oncology procedures, integrating robotics technology, and fostering collaborations with other firms and research institutions to expedite product innovation and development.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
What Core Market Drivers Are Expanding The Interventional Oncology Devices Industry?
Leading companies in the interventional oncology devices market are concentrating on technologies, including tissue volume, to elevate diagnostic precision and treatment success in oncology procedures. Tissue volume denotes the quantity of biological tissue harvested during a biopsy. Increased tissue volumes yield more comprehensive samples, which subsequently enhances diagnostic accuracy and refines treatment planning. For example, in June 2023, Argon Medical, a US-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy. This device can obtain up to 35% more samples than prominent competitors, thereby reducing the requirement for multiple passes during biopsies. Such a feature is crucial for securing adequate tissue samples vital for an accurate diagnosis.
What Segment Insights Are Highlighted In The Interventional Oncology Devices Market Report?
The interventional oncology devicesmarket covered in this report is segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems
Which Notable Trends Are Transforming The Interventional Oncology Devices Market Outlook?
Leading corporations are concentrating on the implementation of robotics technology in interventional oncology devices to achieve enhanced efficiency. This robotic system seamlessly combines image-based planning and navigation with the precise insertion of various instruments into the intended body part, resulting in improved accuracy and effectiveness. An example of this is the U.S. Food and Drug Administration’s approval of Quantum Surgical’s Epione interventional oncology robotics platform in March 2022.
Which Firms Are Driving Innovation Within The Interventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International
Download The Full Report Here:
What Regional Trends Are Shaping Growth In The Interventional Oncology Devices Market?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp
Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2025, By The Business Research Company
Oncology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report
3D Medical Imaging Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report
Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model